Netherlands· NL-cdc781e31e9a

Striverdi Respimat 2,5 microgram, inhalatieoplossing

A olodaterol product containing olodaterolhydrochloride, registered in Netherlands by Boehringer Ingelheim International GmbH. The same ATC class is registered in 14 of our 19 countries.

ATC R03AC19

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about olodaterolhydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Olodaterol is registered in 14 of 19 countries.

Countries holding a registration under ATC R03AC19 (olodaterol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search olodaterol products by name

Olodaterol · ATC R03AC19

14 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olodaterol costs, country by country.

Normalised to the WHO defined daily dose (5 mcg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Olodaterol · price per daily dose (5 mcg)

USD · FX 28 Sept 2026

CH Switzerland$1.64

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OLODATEROLHYDROCHLORIDE
Manufacturer: Boehringer Ingelheim International GmbH
Country: Netherlands (NL)
ATC code: R03AC19
ATC class: Olodaterol
Defined daily dose: 5 mcg, Inhal
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
112058

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

386 interactions on record for olodaterol.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check olodaterol against other medicines How interaction checks work

Olodaterol · interactions on record

386 records

20 severe
365 moderate
1 minor

Most severe, free to view

PindololC07AA03severe
PropranololC07AA05severe
TimololC07AA06severe
SotalolC07AA07severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olodaterol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olodaterol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Striverdi Respimat
Belgium · Striverdi Respimat
Bulgaria · Стриверди Респимат
Cyprus · Striverdi Respimat
Czechia · Striverdi Respimat
Germany · Striverdi Respimat
Denmark · Striverdi Respimat
Estonia · Striverdi Respimat
Spain · Striverdi Respimat
Finland · Striverdi Respimat
France · Striverdi Respimat
United Kingdom (Northern Ireland) · Striverdi Respimat
Greece · Striverdi Respimat
Hungary · Striverdi Respimat
Ireland · Striverdi Respimat
Iceland · Striverdi Respimat
Italy · Striverdi Respimat
Liechtenstein · Striverdi Respimat
Lithuania · Striverdi Respimat
Luxembourg · Striverdi Respimat
Latvia · Striverdi Respimat
Malta · Striverdi Respimat
Norway · Striverdi Respimat
Poland · Striverdi Respimat
Portugal · Striverdi Respimat
Romania · Striverdi Respimat
Sweden · Striverdi Respimat
Slovenia · Striverdi Respimat
Slovakia · Striverdi Respimat

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/08f4a379-05fe-446b-aaf1-09fdd9e87f93
GET /v1/drugs/08f4a379-05fe-446b-aaf1-09fdd9e87f93?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Inhalatieoplossing",
  "route": "Inhalatie",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h112058_smpc.pdf",
  "strength": null,
  "atc_label": "Olodaterol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg112058",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "CITROENZUUR 0-WATER (E 330)",
    "DINATRIUMEDETAAT 2-WATER",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "OLODATEROLHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h112058.pdf",
  "authorised_at": "2013/10/23",
  "procedure_number": "NL/H/2498/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "112058",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about olodaterol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console